Sinco Pharmaceuticals Holdings Limited

SEHK:6833 Rapport sur les actions

Capitalisation boursière : HK$370.0m

Sinco Pharmaceuticals Holdings Bilan de santé

Santé financière contrôle des critères 5/6

Sinco Pharmaceuticals Holdings possède un total de capitaux propres de CN¥644.7M et une dette totale de CN¥327.3M, ce qui porte son ratio d'endettement à 50.8%. Son actif total et son passif total sont CN¥1.8B et de CN¥1.2B. L'EBIT de Sinco Pharmaceuticals Holdings est CN¥131.5M ce qui fait que son ratio de couverture des intérêts 158.6. Elle dispose de liquidités et de placements à court terme de CN¥282.0M.

Informations clés

50.8%

Ratio d'endettement

CN¥327.33m

Dette

Ratio de couverture des intérêts158.6x
Argent liquideCN¥282.01m
Fonds propresCN¥644.70m
Total du passifCN¥1.17b
Total des actifsCN¥1.82b

Mises à jour récentes de la santé financière

Recent updates

Lacklustre Performance Is Driving Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 26% Price Drop

Nov 20
Lacklustre Performance Is Driving Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 26% Price Drop

What Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 32% Share Price Gain Is Not Telling You

Oct 04
What Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 32% Share Price Gain Is Not Telling You

Risks To Shareholder Returns Are Elevated At These Prices For Sinco Pharmaceuticals Holdings Limited (HKG:6833)

Aug 16
Risks To Shareholder Returns Are Elevated At These Prices For Sinco Pharmaceuticals Holdings Limited (HKG:6833)

Some Investors May Be Willing To Look Past Sinco Pharmaceuticals Holdings' (HKG:6833) Soft Earnings

Apr 02
Some Investors May Be Willing To Look Past Sinco Pharmaceuticals Holdings' (HKG:6833) Soft Earnings

Sinco Pharmaceuticals Holdings Limited (HKG:6833) Might Not Be As Mispriced As It Looks

Mar 08
Sinco Pharmaceuticals Holdings Limited (HKG:6833) Might Not Be As Mispriced As It Looks

Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?

Nov 07
Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?

A Look At The Intrinsic Value Of Sinco Pharmaceuticals Holdings Limited (HKG:6833)

Jun 26
A Look At The Intrinsic Value Of Sinco Pharmaceuticals Holdings Limited (HKG:6833)

Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?

May 30
Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?

Sinco Pharmaceuticals Holdings (HKG:6833) Has A Pretty Healthy Balance Sheet

Oct 26
Sinco Pharmaceuticals Holdings (HKG:6833) Has A Pretty Healthy Balance Sheet

Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Might Deserve Your Attention Today

Feb 04
Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Might Deserve Your Attention Today

I Ran A Stock Scan For Earnings Growth And Sinco Pharmaceuticals Holdings (HKG:6833) Passed With Ease

Oct 25
I Ran A Stock Scan For Earnings Growth And Sinco Pharmaceuticals Holdings (HKG:6833) Passed With Ease

Little Excitement Around Sinco Pharmaceuticals Holdings Limited's (HKG:6833) Earnings

Jun 10
Little Excitement Around Sinco Pharmaceuticals Holdings Limited's (HKG:6833) Earnings

Sinco Pharmaceuticals Holdings (HKG:6833) Could Easily Take On More Debt

May 24
Sinco Pharmaceuticals Holdings (HKG:6833) Could Easily Take On More Debt

Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Is An Interesting Stock

Apr 20
Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Is An Interesting Stock

We're Not So Sure You Should Rely on Sinco Pharmaceuticals Holdings' (HKG:6833) Statutory Earnings

Feb 16
We're Not So Sure You Should Rely on Sinco Pharmaceuticals Holdings' (HKG:6833) Statutory Earnings

How Much Did Sinco Pharmaceuticals Holdings'(HKG:6833) Shareholders Earn From Share Price Movements Over The Last Three Years?

Jan 11
How Much Did Sinco Pharmaceuticals Holdings'(HKG:6833) Shareholders Earn From Share Price Movements Over The Last Three Years?

Should You Be Excited About Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 51% Return On Equity?

Dec 07
Should You Be Excited About Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 51% Return On Equity?

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de 6833 ( CN¥1.3B ) dépassent ses passifs à court terme ( CN¥1.1B ).

Passif à long terme: Les actifs à court terme de 6833 ( CN¥1.3B ) dépassent ses passifs à long terme ( CN¥29.9M ).


Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de 6833 ( 7% ) est considéré comme satisfaisant.

Réduire la dette: Le ratio d'endettement de 6833 a été réduit de 369.6% à 50.8% au cours des 5 dernières années.

Couverture de la dette: Le flux de trésorerie opérationnel de 6833 est négatif, par conséquent la dette n'est pas bien couverte.

Couverture des intérêts: Les paiements d'intérêts de 6833 sur sa dette sont bien couverts par l'EBIT ( 158.6 x couverture).


Bilan


Découvrir des entreprises saines